Cargando…
Natriuretic Peptides: Prediction of Cardiovascular Disease in the General Population and High Risk Populations
The natriuretic peptides, especially the B-type peptide (BNP) and its inactive split-product N-terminal proBNP (Nt-proBNP) are increasingly used in screening for heart failure, primarily with reduced systolic function, in patients with symptoms suggestive of heart failure, as well in the stable (Gen...
Autor principal: | Hildebrandt, Per |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3833235/ https://www.ncbi.nlm.nih.gov/pubmed/19773612 http://dx.doi.org/10.3233/DMA-2009-0632 |
Ejemplares similares
-
Natriuretic peptides in cardiovascular diseases
por: Piechota, Mariusz, et al.
Publicado: (2008) -
NATRIURETIC PEPTIDE SYSTEM AND CARDIOVASCULAR DISEASE
por: Federico, Cacciapuoti
Publicado: (2010) -
Natriuretic Peptide and Cardiovascular Risk: Is It About “U”?
por: deFilippi, Christopher R, et al.
Publicado: (2015) -
Cardiac Natriuretic Peptides, Hypertension and Cardiovascular Risk
por: Sarzani, Riccardo, et al.
Publicado: (2017) -
Natriuretic Peptides and Assessment of Cardiovascular Disease Risk in Asymptomatic Persons
por: Daniels, Lori B.
Publicado: (2010)